Why did I choose diagnostics? I am an optimist. I see possibility in everything we do. Today we are delivering clinical utility—real value—by changing clinical practice. Real People, Real Science, Real Answers. BONNIE H. ANDERSON Cofounder and Executive Chairwoman OUR IMPACT LATEST NEWS New Data Presented At ASTRO 2021 Validate Prognostic Ability Of Decipher Prostate Genomic Classifier LEARN MORE > LATEST NEWS Veracyte Unveils Expanded Clinical Validation Data For Noninvasive Nasal Swab Test To Improve Early Lung Cancer Risk Assessment LEARN MORE > WATCH Bonnie Anderson, cofounder and executive chairwoman, on what it takes to make a meaningful and lasting impact on cancer diagnostics WATCH NOW > LATEST NEWS NEWS AND UPDATES ASCO: New data set up Veracyte’s nasal swab lung cancer test for launch later this year Fierce Biotech May 19, 2021 Hormone Therapy for Prostate Cancer? A Genetic Test Could Help Decide Cancer Currents Blog, National Cancer Institute Mar 15, 2021 Meet 22 women who launched and led startups to an IPO, an accomplishment few female founders have ever reached Business Insider Feb 9, 2021 TWITTER About Diagnostics Biopharma & IVD Services Immuno-Oncology News & Events Investors Veracyte Headquarters 6000 Shoreline Court Suite 300 South San Francisco, CA 94080 Phone: (650) 243-6300 Fax: (650) 243-6301 Driving Directions Veracyte Labs SD 6925 Lusk Boulevard Suite 200 San Diego, CA 92121 Phone: 1 (888) 792-1601 Fax: (858) 766-6575 Driving Directions Veracyte Labs AUS 12357-A Riata Trace Parkway Building 5, Suite 100 Austin, TX 78727 Driving Directions Veracyte Labs VA 737N 5th Street Suite 600 Richmond, VA 23219 Driving Directions Veracyte EU Headquarters Luminy Biotech Entreprises 163 Avenue de Luminy 13288 Marseille Cedex 9 FRANCE Phone: +33 (0) 4 91 29 30 90 Fax: +33 (0) 4 91 29 30 99 Veracyte Canada 1120 Hamilton Street Unit 201 Vancouver, BC V6B 2S2 CANADA © 2021 Veracyte, Inc. All rights reserved. Contact Us Privacy Information Center | Terms of Use | Terms of Sale